9.16
0.02 (0.22%)
| Penutupan Terdahulu | 9.14 |
| Buka | 9.14 |
| Jumlah Dagangan | 584,297 |
| Purata Dagangan (3B) | 2,125,430 |
| Modal Pasaran | 1,458,944,000 |
| Harga / Pendapatan (P/E TTM) | 130.86 |
| Harga / Pendapatan (P/E Ke hadapan) | 17.89 |
| Harga / Jualan (P/S) | 3.55 |
| Harga / Buku (P/B) | 1.37 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | -0.67% |
| Margin Operasi (TTM) | 7.19% |
| EPS Cair (TTM) | -0.020 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 9.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 28.51% |
| Nisbah Semasa (MRQ) | 2.78 |
| Aliran Tunai Operasi (OCF TTM) | 93.52 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 71.36 M |
| Pulangan Atas Aset (ROA TTM) | 1.12% |
| Pulangan Atas Ekuiti (ROE TTM) | -0.25% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Menurun | Bercampur |
| Health Information Services (Global) | Menurun | Bercampur | |
| Stok | Certara, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -4.0 |
| Purata | -0.75 |
|
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 2.48% |
| % Dimiliki oleh Institusi | 100.90% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 16.00 (Keybanc, 74.67%) | Beli |
| 16.00 (Craig-Hallum, 74.67%) | Beli | |
| Median | 15.00 (63.76%) | |
| Rendah | 9.00 (BMO Capital, -1.75%) | Pegang |
| Purata | 13.75 (50.11%) | |
| Jumlah | 3 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 10.57 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BMO Capital | 13 Nov 2025 | 9.00 (-1.75%) | Pegang | 8.41 |
| Barclays | 07 Nov 2025 | 14.00 (52.84%) | Beli | 8.67 |
| 02 Oct 2025 | 16.00 (74.67%) | Beli | 13.60 | |
| Keybanc | 08 Oct 2025 | 16.00 (74.67%) | Beli | 13.00 |
| Craig-Hallum | 29 Sep 2025 | 16.00 (74.67%) | Beli | 12.18 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 06 Nov 2025 | Pengumuman | Certara Reports Third Quarter 2025 Financial Results |
| 04 Nov 2025 | Pengumuman | Certara Automates Scientific Workflows with Phoenix® Cloud |
| 31 Oct 2025 | Pengumuman | Certara to Participate in Upcoming Investor Conferences |
| 30 Oct 2025 | Pengumuman | Certara Expands Biosimulation Market with AI-Driven QSP Platform |
| 20 Oct 2025 | Pengumuman | Certara Scientists are Among the Topmost Cited Biopharma Researchers |
| 10 Oct 2025 | Pengumuman | Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |